Pfizer Inc. (NYSE:PFE) on Friday released results from the Phase 3 THRIVE-131 study evaluating inclacumab, an investigational P-selectin inhibitor, in patients 16 years of age and older with sickle ...

Aug 15 (Reuters) - In the latest setback for Pfizer's (PFE.N), opens new tab sickle cell anemia treatments, experimental drug inclacumab failed to meet the main goal in a late-stage trial for patients ...

OMAHA, Neb. (WOWT) - Nobel Prize-winning technology offers a potential cure for sickle cell disease. Simply put, doctors can edit a patient’s genes to alter blood cells. But this gene editing ...

A Pfizer drug designed to address a severe problem associated with sickle cell disease failed to beat a placebo in a Phase 3 clinical trial. It’s the latest setback for Pfizer in this inherited blood ...

Reeves is an associate professor of pediatrics and epidemiology at the University of Michigan and the principal investigator of the Michigan Sickle Cell Data Collection program. In December 2023, a ...

CHESTERFIELD, Va. (WRIC) — As September marks National Sickle Cell Disease Awareness Month, a local man’s story highlights a critical need in the community — compatible blood donations. For more than ...

RICHMOND, Va. — Going to the movies, hanging out with friends, playing video games — Jamal Bailey is your typical young adult who likes walking. But sometimes even something as simple as walking can ...

NEW ORLEANS — A 22-year-old man is hoping to become the very first person in the state to be cured of his sickle cell disease with a new treatment. Daniel Cressy has dreams of becoming a pilot one day ...

GRAND RAPIDS, Mich. — The Price family navigates daily life with love and laughter, while three of their children—Canaan, Brielle and Julia—face the challenges of sickle cell. “I don't think there's ...